ZA200107785B - Pet food for maintenance of joint health and alleviation of arthiritic symptoms in companion animals. - Google Patents
Pet food for maintenance of joint health and alleviation of arthiritic symptoms in companion animals. Download PDFInfo
- Publication number
- ZA200107785B ZA200107785B ZA200107785A ZA200107785A ZA200107785B ZA 200107785 B ZA200107785 B ZA 200107785B ZA 200107785 A ZA200107785 A ZA 200107785A ZA 200107785 A ZA200107785 A ZA 200107785A ZA 200107785 B ZA200107785 B ZA 200107785B
- Authority
- ZA
- South Africa
- Prior art keywords
- pet food
- extract
- dogs
- food product
- glmp
- Prior art date
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 84
- 241001465754 Metazoa Species 0.000 title claims abstract description 46
- 208000024891 symptom Diseases 0.000 title claims abstract description 39
- 230000037231 joint health Effects 0.000 title claims abstract description 24
- 238000012423 maintenance Methods 0.000 title claims abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 64
- 230000002917 arthritic effect Effects 0.000 claims abstract description 48
- 241001537211 Perna canaliculus Species 0.000 claims abstract description 40
- 150000002632 lipids Chemical class 0.000 claims abstract description 33
- 239000000843 powder Substances 0.000 claims abstract description 23
- 241001537210 Perna Species 0.000 claims 2
- 238000000034 method Methods 0.000 abstract description 18
- 230000008569 process Effects 0.000 abstract description 14
- 230000037396 body weight Effects 0.000 abstract description 10
- 241000282472 Canis lupus familiaris Species 0.000 description 74
- 102100025888 Glycosylated lysosomal membrane protein Human genes 0.000 description 43
- 101000857309 Homo sapiens Glycosylated lysosomal membrane protein Proteins 0.000 description 43
- 238000005303 weighing Methods 0.000 description 17
- 241000237536 Mytilus edulis Species 0.000 description 13
- 230000003110 anti-inflammatory effect Effects 0.000 description 13
- 230000009467 reduction Effects 0.000 description 13
- 235000020638 mussel Nutrition 0.000 description 11
- 201000008482 osteoarthritis Diseases 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- 238000012545 processing Methods 0.000 description 10
- 210000002808 connective tissue Anatomy 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 206010003246 arthritis Diseases 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 7
- 230000037213 diet Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 241000282326 Felis catus Species 0.000 description 6
- 241000282412 Homo Species 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000007921 spray Substances 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 210000001503 joint Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 206010039073 rheumatoid arthritis Diseases 0.000 description 5
- 210000001188 articular cartilage Anatomy 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 241000283086 Equidae Species 0.000 description 3
- 241000283073 Equus caballus Species 0.000 description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 210000001179 synovial fluid Anatomy 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000002456 anti-arthritic effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000004464 cereal grain Substances 0.000 description 2
- 239000003042 chondroprotective agent Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 229940012843 omega-3 fatty acid Drugs 0.000 description 2
- 230000003349 osteoarthritic effect Effects 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JDKIKEYFSJUYJZ-UHFFFAOYSA-N (5Z,11Z,14Z,17Z)-5,11,14,17-Eicosatetraenoic acid Natural products CCC=CCC=CCC=CCCCCC=CCCCC(O)=O JDKIKEYFSJUYJZ-UHFFFAOYSA-N 0.000 description 1
- JDKIKEYFSJUYJZ-MLPCWCQHSA-N (5e,11e,14e,17e)-icosa-5,11,14,17-tetraenoic acid Chemical compound CC\C=C\C\C=C\C\C=C\CCCC\C=C\CCCC(O)=O JDKIKEYFSJUYJZ-MLPCWCQHSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 102000003820 Lipoxygenases Human genes 0.000 description 1
- 108090000128 Lipoxygenases Proteins 0.000 description 1
- 102000055008 Matrilin Proteins Human genes 0.000 description 1
- 108010072582 Matrilin Proteins Proteins 0.000 description 1
- 208000001294 Nociceptive Pain Diseases 0.000 description 1
- 206010036030 Polyarthritis Diseases 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000012223 aqueous fraction Substances 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 208000018937 joint inflammation Diseases 0.000 description 1
- 208000030175 lameness Diseases 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- -1 lipid compounds Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 239000006014 omega-3 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 208000030428 polyarticular arthritis Diseases 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000005065 subchondral bone plate Anatomy 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 230000008409 synovial inflammation Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000010119 systemic immune function Effects 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/805—Pet food for dog, cat, bird, or fish
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Birds (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Feed For Specific Animals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/273,933 US6596303B1 (en) | 1999-03-22 | 1999-03-22 | Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200107785B true ZA200107785B (en) | 2002-09-20 |
Family
ID=23046040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200107785A ZA200107785B (en) | 1999-03-22 | 2001-09-20 | Pet food for maintenance of joint health and alleviation of arthiritic symptoms in companion animals. |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6596303B1 (pt) |
| EP (1) | EP1164863B1 (pt) |
| JP (1) | JP2002538845A (pt) |
| KR (1) | KR20020019893A (pt) |
| CN (1) | CN1142718C (pt) |
| AT (1) | ATE539618T1 (pt) |
| AU (1) | AU3907800A (pt) |
| BR (1) | BR0009219A (pt) |
| CA (1) | CA2364847A1 (pt) |
| MX (1) | MXPA01009594A (pt) |
| NZ (1) | NZ514389A (pt) |
| RU (1) | RU2230458C2 (pt) |
| WO (1) | WO2000056164A1 (pt) |
| ZA (1) | ZA200107785B (pt) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU761829B2 (en) * | 1999-07-21 | 2003-06-12 | Bomac Laboratories Limited | Compositions addressing inflammation and/or degenerative disorders |
| WO2001021008A2 (en) * | 1999-09-22 | 2001-03-29 | Societe Des Produits Nestle S.A. | Method for increasing pet activity |
| AU2001249348A1 (en) * | 2000-03-22 | 2001-10-03 | Creighton University | Compositions derived from modiolus modiolus and methods for making and using same |
| RU2324367C2 (ru) * | 2001-09-18 | 2008-05-20 | Нестек С.А. | Корм для домашних животных и способ его производства |
| WO2004082614A2 (en) * | 2003-03-14 | 2004-09-30 | Foodscience Corporation | Methods for treating cancer using perna canaliculus component(s) and extracts of perna canaliculus |
| US8633246B2 (en) * | 2003-08-11 | 2014-01-21 | Hill's Pet Nutrition, Inc. | Omega-3 fatty acids for osteoarthritis |
| US8633247B2 (en) * | 2003-08-11 | 2014-01-21 | Hill's Pet Nutrition, Inc. | Method for decreasing cartilage damage in dogs |
| US7335686B2 (en) * | 2003-10-20 | 2008-02-26 | Council Of Scientific And Industrial Research | Method and composition for treating osteoporosis |
| CA2554932A1 (en) * | 2004-01-30 | 2005-08-11 | Bionovate Limited | Solvent extraction of lipids such as essential fatty acids |
| GB0411166D0 (en) * | 2004-05-19 | 2004-06-23 | Bionovate Ltd | Treatment for asthma and arthritis |
| GB0411165D0 (en) * | 2004-05-19 | 2004-06-23 | Bionovate Ltd | Hyaluronic acid containing pharmaceutical or veterinary compounds |
| US9480275B2 (en) * | 2005-05-20 | 2016-11-01 | Mars Incorporated | Coated pet food products |
| WO2007002837A2 (en) * | 2005-06-29 | 2007-01-04 | Hill's Pet Nutrition, Inc. | Methods and compositions for the prevention and treatement of inflammatory disease |
| EP1986508B1 (en) * | 2006-01-26 | 2014-05-21 | Hill's Pet Nutrition, Inc. | Methods and compositions for treating feline hyperthyroidism |
| US20080260906A1 (en) * | 2006-03-17 | 2008-10-23 | Marko Stojanovic | Compositions comprising probiotic and sweetener components |
| US9549959B2 (en) * | 2006-09-15 | 2017-01-24 | I Did It, Inc. | Animal chew toy containing solid food |
| US8703174B2 (en) * | 2006-09-15 | 2014-04-22 | I Did It Inc | Joint preserving nutritional vitamin, mineral and herbal pet supplement |
| WO2008035756A1 (fr) * | 2006-09-22 | 2008-03-27 | Heimat Co., Ltd. | Composition anti-angiogénique comportant un extrait ayant une activité anti-angiogénique et une lécithine |
| CN101167526B (zh) * | 2006-10-26 | 2011-07-20 | 天津瑞普生物技术股份有限公司 | 一种具有促生长作用的犬猫用保健品 |
| NZ552238A (en) | 2006-12-20 | 2009-07-31 | Seperex Nutritionals Ltd | An extract |
| CA2698051C (en) * | 2007-08-29 | 2016-02-16 | Mars, Incorporated | Single-serve cat food product and methods for same |
| WO2009117584A2 (en) * | 2008-03-20 | 2009-09-24 | Lynn Chambers | Anti-inflammatory drug delivery system |
| US20110052752A1 (en) * | 2009-08-25 | 2011-03-03 | GlobalOne Pet Products, Inc. | Rotational pet-food formulation and method |
| US8293299B2 (en) | 2009-09-11 | 2012-10-23 | Kraft Foods Global Brands Llc | Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable Concentrated liquids |
| DE102010003550B4 (de) * | 2010-03-31 | 2015-04-16 | Vievital Gmbh | Futtermittel zur Vorbeugung und Linderung von Gelenkbeschwerden |
| JP6027978B2 (ja) | 2010-12-23 | 2016-11-16 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 関節炎および関節炎に関連する炎症を治療するためのペットフード組成物および方法 |
| CA2834259A1 (en) * | 2011-04-29 | 2012-11-01 | Nestec S.A. | Palatability enhancing compositions |
| US11013248B2 (en) | 2012-05-25 | 2021-05-25 | Kraft Foods Group Brands Llc | Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings |
| US9695253B2 (en) | 2014-03-11 | 2017-07-04 | E I Du Pont De Nemours And Company | Oxidized poly alpha-1,3-glucan |
| AU2015369965B2 (en) | 2014-12-23 | 2020-01-30 | Nutrition & Biosciences USA 4, Inc. | Enzymatically produced cellulose |
| CA2975217C (en) | 2015-02-13 | 2023-08-15 | Mars, Incorporated | Pet food feeding system |
| WO2016160738A2 (en) | 2015-04-03 | 2016-10-06 | E I Du Pont De Nemours And Company | Gelling dextran ethers |
| GB201522304D0 (en) | 2015-12-17 | 2016-02-03 | Mars Inc | Food product for reducing muscle breakdown |
| CN105727249A (zh) * | 2016-03-24 | 2016-07-06 | 河南牧业经济学院 | 治疗猫、犬关节病症的外用膏剂及其制备方法 |
| CN106692333A (zh) * | 2016-12-21 | 2017-05-24 | 泰州市贝诺生物科技有限公司 | 一种氨糖壮骨关节膏及其制备方法 |
| HRP20231254T1 (hr) | 2017-12-22 | 2024-02-02 | Pharmalink International Limited | Kompozicije koje sadrže ekstrakt lipida dagnјi i ulje krila, i nјihove medicinske primjene |
| CN109527251A (zh) * | 2018-12-26 | 2019-03-29 | 江苏雅博动物健康科技有限责任公司 | 宠物用软糖及其制备方法 |
| US11690878B2 (en) | 2020-01-21 | 2023-07-04 | Lintbells Limited | Synergistic compositions |
| CN113797310B (zh) * | 2020-06-15 | 2024-04-12 | 中农极润生物科技(北京)有限公司 | 一种宠物关节保健制剂及其制备方法和应用 |
| KR20230109459A (ko) | 2022-01-13 | 2023-07-20 | 강도한 | 애완동물의 근육조직 및 연골조직 수복용 조성물 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3807926A (en) * | 1972-04-06 | 1974-04-30 | G Morse | Pellet mill with positive feed |
| EP0010061B1 (en) | 1978-09-25 | 1983-07-13 | Stuart John Mc Farlane | Pharmaceutical preparations containing a mollusc extract |
| DE3162429D1 (en) * | 1980-07-02 | 1984-04-05 | Buehler Ag Geb | Pellet press |
| US4801453A (en) * | 1984-05-01 | 1989-01-31 | James M. Broadbent | Stabilized mussel extract |
| JP2919496B2 (ja) | 1989-08-24 | 1999-07-12 | 生化学工業株式会社 | 新規コンドロイチン硫酸分解酵素、それらを産生する微生物並びにそれらの製法 |
| RU2017439C1 (ru) | 1992-11-12 | 1994-08-15 | Рехина Надежда Ивановна | Продукт из мяса мидий и способ его получения |
| US5364845C1 (en) | 1993-03-31 | 2002-09-10 | Nutramax Lab Inc | Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue |
| SE9401738D0 (sv) * | 1994-05-19 | 1994-05-19 | Ewos Ab | Bioactive feed |
| AUPM740594A0 (en) | 1994-08-11 | 1994-09-01 | J.W. Broadbent Nominees Pty. Ltd. | Anti-inflammatory preparation |
| NZ270754A (en) | 1995-03-20 | 1997-08-22 | Mcfarlane Lab Nz Ltd | Mussel/fish oil mixture; finely ground, freeze-dried green-lipped mussel (perna canaliculus) suspended in fish oil; encapsulated mixture with anti-inflammatory activity |
| AUPN531195A0 (en) * | 1995-09-11 | 1995-10-05 | J.W. Broadbent Nominees Pty. Ltd. | Lipid extract having anti-inflamatory activity |
| EP0855908B1 (en) | 1995-12-11 | 2002-02-06 | Omni Nutraceuticals, Inc. | Dietary regimen of nutritional supplements for relief of symptoms of arthritis |
| RU2097982C1 (ru) | 1996-02-14 | 1997-12-10 | Беседина Тамара Васильевна | Кормовая добавка |
| GB2313035B (en) * | 1996-05-15 | 1999-07-21 | Ewos Ab | Method for producing feed pellets |
| US5843919A (en) * | 1996-11-25 | 1998-12-01 | Burger; John A. | Composition and method for the treatment of arthritis |
| DE29724815U1 (de) * | 1997-01-09 | 2004-07-22 | Société des Produits Nestlé S.A. | Probiotik enthaltendes Getreideprodukt |
| DE19838794A1 (de) * | 1998-08-26 | 2000-03-09 | Aristavet Veterinaerspezialita | Zusammensetzung zur Behandlung von Osteoarthritis und zur nutritiven Behandlung des Gelenkknorpels |
| AU4754099A (en) * | 1998-10-08 | 2000-04-13 | Consolidated Process Machinery, Inc. | Stationary die pellet mill |
-
1999
- 1999-03-22 US US09/273,933 patent/US6596303B1/en not_active Expired - Lifetime
-
2000
- 2000-03-21 BR BR0009219-3A patent/BR0009219A/pt not_active Application Discontinuation
- 2000-03-21 KR KR1020017012077A patent/KR20020019893A/ko not_active Application Discontinuation
- 2000-03-21 JP JP2000606081A patent/JP2002538845A/ja active Pending
- 2000-03-21 WO PCT/US2000/007533 patent/WO2000056164A1/en not_active Application Discontinuation
- 2000-03-21 CA CA002364847A patent/CA2364847A1/en not_active Abandoned
- 2000-03-21 AU AU39078/00A patent/AU3907800A/en not_active Abandoned
- 2000-03-21 RU RU2001128302/13A patent/RU2230458C2/ru active
- 2000-03-21 AT AT00918229T patent/ATE539618T1/de active
- 2000-03-21 NZ NZ514389A patent/NZ514389A/en not_active Application Discontinuation
- 2000-03-21 CN CNB008078424A patent/CN1142718C/zh not_active Expired - Lifetime
- 2000-03-21 MX MXPA01009594A patent/MXPA01009594A/es unknown
- 2000-03-21 EP EP00918229A patent/EP1164863B1/en not_active Expired - Lifetime
-
2001
- 2001-09-20 ZA ZA200107785A patent/ZA200107785B/en unknown
-
2003
- 2003-02-04 US US10/357,607 patent/US6977084B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2364847A1 (en) | 2000-09-28 |
| CN1351471A (zh) | 2002-05-29 |
| US6596303B1 (en) | 2003-07-22 |
| BR0009219A (pt) | 2002-05-21 |
| RU2230458C2 (ru) | 2004-06-20 |
| CN1142718C (zh) | 2004-03-24 |
| AU3907800A (en) | 2000-10-09 |
| NZ514389A (en) | 2003-08-29 |
| EP1164863A4 (en) | 2004-04-07 |
| KR20020019893A (ko) | 2002-03-13 |
| US20030124219A1 (en) | 2003-07-03 |
| JP2002538845A (ja) | 2002-11-19 |
| EP1164863A1 (en) | 2002-01-02 |
| US6977084B2 (en) | 2005-12-20 |
| MXPA01009594A (es) | 2002-08-12 |
| WO2000056164A1 (en) | 2000-09-28 |
| ATE539618T1 (de) | 2012-01-15 |
| EP1164863B1 (en) | 2012-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6596303B1 (en) | Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals | |
| DE3687996T2 (de) | Methylsulfonylmethan enthaltende ernaehrungsprodukte und deren verwendungen. | |
| EP1694137B1 (en) | Method to reduce stool odor of companion animals | |
| AU785003B2 (en) | Skin Diet | |
| EP2387325B1 (en) | Methods for improving hepatic and immune function in an animal | |
| US20120231087A1 (en) | Compositions And Methods for Nutritional Supplementation | |
| EP1317188B2 (de) | Verwendung von benzophenanthridinalkaloiden als futterzusatzmittel | |
| US20110052751A1 (en) | Feed composition for companion animals | |
| EP2931059B1 (en) | Anti-aging foods for companion animals | |
| WO2011087706A1 (en) | Animal food compositions | |
| US20210401738A1 (en) | Dietary supplement compositions | |
| CA3164450A1 (en) | Pet food compositions | |
| JP2000279129A (ja) | 食物補助剤、これを含む食物製品、及びこれらの使用方法 | |
| JP2003504408A (ja) | 炎症及び／又は退行性疾患に対処する組成物 | |
| AU2005200953B2 (en) | Pet food for maintenance of joint health and alleviation of arthritic symptoms in companion animals and method of manufacturing same | |
| WO2024076759A1 (en) | Small dog food composition | |
| Adesehinwa et al. | Effect of Macleaya cordata Preparation as Phytobiotic Feed Additive on the Performance and Blood Profiles of Weaned Pigs | |
| EP3466428A1 (de) | Tiernahrung mit febrifugin zur leistungssteigerung | |
| DE19523394A1 (de) | Verwendung von Balhimycin zur Leistungssteigerung bei Tieren sowie leistungssteigernde Mittel |